Emmessar Biotech to hold AGM on Sept 29; reappoints MD, WTD
- Emmessar Biotech schedules its 34th AGM for September 29, 2026
- Shareholders to reappoint MD Srinivasa Raghavan Mathurakavi Ayyangar for five years
- WTD Jeyavel Balaiah Nadar seeks reappointment until February 2031
- Remote e-voting opens on September 26 with a cutoff date of September 22

*this image is generated using AI for illustrative purposes only.
Emmessar Biotech has scheduled its 34th Annual General Meeting for September 29, 2026. The meeting will be conducted via video conferencing or other audio-visual means, as permitted by Ministry of Corporate Affairs circulars.
The primary agenda involves the reappointment of key management personnel. Shareholders will vote on the five-year reappointment of Srinivasa Raghavan Mathurakavi Ayyangar as Managing Director and Jeyavel Balaiah Nadar as Whole-time Director.
Management Reappointments
The Board proposes extending the tenure of Mr. Ayyangar from April 20, 2027, to April 19, 2032. His proposed monthly salary scale ranges from ₹2,20,000 to ₹4,00,000. Perquisites are capped at 50% of his salary and include housing, medical benefits, and club memberships.
Mr. Nadar’s reappointment covers the period from February 6, 2026, to February 5, 2031. His proposed salary scale is set between ₹1,20,000 and ₹2,50,000 per month. The resolution also seeks ratification of his acts and remuneration up to the date of the resolution.
| Director | Role | Tenure Period | Proposed Salary Scale (Monthly) |
|---|---|---|---|
| Srinivasa Raghavan Mathurakavi Ayyangar | Managing Director | April 20, 2027 – April 19, 2032 | ₹2,20,000 – ₹4,00,000 |
| Jeyavel Balaiah Nadar | Whole-time Director | February 6, 2026 – February 5, 2031 | ₹1,20,000 – ₹2,50,000 |
Governance and Voting
Mr. Jeyavel Balaiah Nadar also retires by rotation and offers himself for re-appointment as a Director. The company confirmed compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, by sending separate letters to shareholders without registered email addresses.
Remote e-voting will commence on September 26, 2026, at 9:00 am and conclude on September 28, 2026, at 5:00 pm. The record date for voting rights is September 22, 2026. Institutional shareholders must upload board resolutions authorizing their representatives to vote.
Historical Stock Returns for Emmessar Biotech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.72% | -2.96% | -3.76% | -6.06% | -13.37% | 0.0% |
How might the five-year tenure extension for the Managing Director influence Emmessar Biotech's long-term strategic roadmap and R&D pipeline stability?
What is the market's likely reaction to the proposed salary scales for key management, particularly in comparison to peer companies in the biotech sector?
Could the reappointment of Jeyavel Balaiah Nadar signal any upcoming shifts in corporate governance or operational focus for the company?
































